Diagnostic accuracy of circulating-free DNA for the determination of MYCN amplification status in advanced-stage neuroblastoma: a systematic review and meta-analysis

BACKGROUND: MYCN amplification (MNA) is the strongest indicator of poor prognosis in neuroblastoma (NB). This meta-analysis aims to determine the diagnostic accuracy of MNA analysis in circulating-free DNA (cfDNA) from advanced-stage NB patients. METHODS: A systematic review of electronic databases...

Descripción completa

Detalles Bibliográficos
Autores principales: Trigg, Ricky M., Turner, Suzanne D., Shaw, Jacqueline A., Jahangiri, Leila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109036/
https://www.ncbi.nlm.nih.gov/pubmed/32015512
http://dx.doi.org/10.1038/s41416-020-0740-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109036/
https://www.ncbi.nlm.nih.gov/pubmed/32015512
http://dx.doi.org/10.1038/s41416-020-0740-y

Ejemplares similares